U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Application of Artificial Intelligence and Machine Learning for Precision Medicine - 02/17/2023
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
Application of Artificial Intelligence and Machine Learning for Precision Medicine
February 17, 2023

Date:
February 17, 2023
Time:
10:00 a.m. - 4:15 p.m. ET

About this Virtual Workshop:

The U.S. Food and Drug Administration (FDA) – in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) – will host a one-day virtual public workshop entitled “Application of Artificial Intelligence and Machine Learning for Precision Medicine” on Friday, February 17, 2023.

The purpose of this workshop is to review current methodologies, opportunities, challenges, and best practices to address the rapidly changing landscape of artificial intelligence and machine learning in the setting of drug development and precision medicine.

Workshop Objectives:

  1. Review progress made from implementing artificial intelligence and machine learning in drug development and precision medicine.
  2. Discuss methodologies and best practices used today in this field.
  3. Discuss technical challenges such as bias, generalizability, and opacity and how they can lead to issues of data disparity, fairness, and trustworthiness. We will also discuss how to address these challenges.

Meeting Information and Registration:

This virtual workshop is open to the public with no cost to attend, but registration is required. For more information and to view the draft Agenda, visit the MCERSI webpage.
 
Contact:

For questions regarding this event, please contact:

Kunal Naik
Office of Clinical Pharmacology
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
OCPWorkshops@fda.hhs.gov

Back to Top